The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
May 7th 2025
Patients with myelofibrosis who stopped ruxolitinib on the first day of conditioning did not show higher rates of acute graft-versus-host disease (GVHD).
Johnson & Johnson Discontinues Phase 3 Study Evaluating Respiratory Syncytial Virus Vaccine
March 30th 2023The company announced the initiation of the EVERGREEN study, which was aimed to evaluate the efficacy, safety, and immunogenicity of the investigational respiratory syncytial virus vaccine, in 2021.
Read More
Pharmacy Focus: Public Health Matters - What is Public Health?
March 30th 2023This month's guest is Jennifer Lind, PharmD, MPH, MBA, a public health pharmacists, epidemiologist in the Medication Safety Program at the CDC, and commander in the United States Public Health Service Commissioned Corps.
Listen